DEVICE IN FOCUS: SHELASE (ADVANCED ESTHETICS SOLUTIONS)
In this issue we speak exclusively to Douglas Sykes from Advanced Esthetics Solutions – the device company behind the Shelase platform.
THSJ: Hi Douglas. Tell the readers about shelase
DS: Shelase is a new hybrid fractional ablative and non-ablative laser treatment providing the use of mixed technology for the treatments of vaginal atrophy and tightening. Unlike other vaginal rejuvenation treatments, this uses mixed technology for fast, safe, reliable and high-quality treatments with no downtime.
THSJ: Who can Shelase help?
DS: Shelase is a non invasive treatment for the symptoms of vaginal atrophy as a result of childbirth or the menopause, so it’s ideal for patients suffering as a result of those factors. The Shelase laser treatment has previously demonstrated significant improvement in GSM symptoms in postmenopausal women.
THSJ: How does it work?
DS: The mixed technology stimulates new collagen formation, supporting the increase of internal hydration and balance with providing minimal post treatment recovery. In turn shelase provides a safe and effective treatment for all patients dealing with one or more vaginal atrophy symptom.
THSJ: How long does a treatment take?
DS: While many women report improvements after one session, sometimes a course is required. A consultation is of course needed to ascertain what level of treatment with Shelase required. Treatments can take as little as 15 minutes.
THSJ: Tell us more about the mixed technology
DS: Shelase can deliver GaAs 1540 nm and CO2 10600 nm lasers in the same micro-dot with sequential or simultaneous emissions to get a tunable balance of ablation and coagulation depth and to offer new and more effective treatment standards to the patients. The mixed modality is scientifically proven to improve symptoms of vaginal atrophy including vaginal itching and stress urinary incontinence, and is a reliable method of treating concerns relating to dryness and discomfort.
THSJ: Why were you keen to add a gynaecological device to your portfolio?
DS: From the age of 45 women suffer with physical conditions associated with vaginal atrophy being stress urinary incontinence, dryness, discomfort, laxity, menopause even with post childbirth causing a negative and distressing effective to a woman’s lifestyle. Shelase treatments have been designed to support and assist these conditions for female wellbeing. We want to help our medical customers help women feel happier and healthier.
THSJ: Why is now the right time to be launching shelase in clinics across the UK?
DS: Women are looking for a mesh-free and non-hormonal treatment for vaginal atrophy symptoms. This laser treatment is a non-hormonal treatment approach for Genitourinary Syndrome of Menopause (GSM). The concept behind laser procedures to treat vulvovaginal conditions is the use of a specific wavelength. A response is initiated due to the ablation and heating and results in tissue remodeling with the reformation of collagen and elastic fibers to the vaginal wall. Muscle tone is then restored by tightening the supportive structures of the vagina. The Shelase device permits a dual laser treatment for effective vaginal mucosa’s resurfacing and tightening. It uses the Mixed Technology to perform an exclusive mixed treatment of the vaginal mucosa by non-ablative and ablative wavelengths in the same time.
THSJ: What makes Shelase unique or innovative to the industry?
DS: The treatment is performed delivering two laser wavelengths in the vaginal tissue to stimulate the production of new collagen to regain the normal vaginal elasticity. It reduces trauma during treatment while the non-ablative laser penetrates deeper into the tissue to maximize the regeneration effect in a gentle way, with no bleeding and no recovery time. The treatment is not invasive and causes very minimal discomfort. The combination of the two laser wavelengths maximizes the effectiveness and the improvement of the overall treatment comfort.
THSJ: Which treatment is proving the most popular with this platform?
DS: Issues associated with vaginal atrophy vary woman to woman, but a common concern under this umbrella is urinary incontinence, and we’re seeing excellent results in this area. A most unwanted and often debilitating side effect of the ageing process, childbirth and even the menopause, urinary incontinence can have a negative affect on a woman’s life, but Shelase can restore balance from within for many women.
THSJ: How have patients responded to Shelase?
DS: We’ve had some excellent feedback from clinics who have already installed the platform. It’s featured in the national press recently too as a go to treatment for women seeking a reliable and safe solution to painful intercourse and vaginal atrophy. We’re really pleased with the reception, not only from patients but also from the gynecology community.
Shelase is a unique procedure that reduces the mucosa’s ablation during treatment while the non-ablative laser penetrates deep into the tissue to maximise the tightening effect in a very gentle way, with no bleeding and no recovery time. For more information about Shelase please contact Advanced Esthetics Solutions on 029 2023 1228 or email@example.com. Alternatively you can visit www.shelase.co.uk